UA122534C2 - Damp-proofing tablet containing choline alfoscerate, and preparation method therefor - Google Patents

Damp-proofing tablet containing choline alfoscerate, and preparation method therefor

Info

Publication number
UA122534C2
UA122534C2 UAA201812799A UAA201812799A UA122534C2 UA 122534 C2 UA122534 C2 UA 122534C2 UA A201812799 A UAA201812799 A UA A201812799A UA A201812799 A UAA201812799 A UA A201812799A UA 122534 C2 UA122534 C2 UA 122534C2
Authority
UA
Ukraine
Prior art keywords
preparation
film
choline alfoscerate
method therefor
containing choline
Prior art date
Application number
UAA201812799A
Other languages
Ukrainian (uk)
Inventor
Даі Айк Кім
Даи Айк Ким
Ву Чіул Шін
Ву Чиул Шин
Янг Сін Парк
Янг Син Парк
Original Assignee
Кореа Прайм Фарм Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кореа Прайм Фарм Ко., Лтд. filed Critical Кореа Прайм Фарм Ко., Лтд.
Publication of UA122534C2 publication Critical patent/UA122534C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D129/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal, or ketal radical; Coating compositions based on hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Coating compositions based on derivatives of such polymers
    • C09D129/02—Homopolymers or copolymers of unsaturated alcohols
    • C09D129/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a film-coated tablet containing choline alfoscerate, and a preparation method therefor. More specifically, the present invention relates to: a film-coated tablet in which a choline alfoscerate tablet having deliquescence is molded and then a film-coated layer is formed by using a specific film-forming agent; and a preparation method therefor. Compared to conventional soft capsule preparations, tablets and/or film-coated tablets, the pharmaceutical preparation of the present invention, containing choline alfoscerate, does not include a separate preparation process and has excellent storage stability and dosing convenience.
UAA201812799A 2016-05-25 2017-05-24 Damp-proofing tablet containing choline alfoscerate, and preparation method therefor UA122534C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160064394A KR101796628B1 (en) 2016-05-25 2016-05-25 Moisture-resistant tablet comprising choline alfoscerate, and method for preparing the same
PCT/KR2017/005391 WO2017204548A1 (en) 2016-05-25 2017-05-24 Damp-proofing tablet containing choline alfoscerate, and preparation method therefor

Publications (1)

Publication Number Publication Date
UA122534C2 true UA122534C2 (en) 2020-11-25

Family

ID=60386665

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201812799A UA122534C2 (en) 2016-05-25 2017-05-24 Damp-proofing tablet containing choline alfoscerate, and preparation method therefor

Country Status (4)

Country Link
KR (1) KR101796628B1 (en)
PH (1) PH12018502287A1 (en)
UA (1) UA122534C2 (en)
WO (1) WO2017204548A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102647890B1 (en) 2018-06-15 2024-03-14 성이바이오제약 주식회사 Pharmaceutical compositions comprising choline alfoscerate
KR102149020B1 (en) 2018-11-20 2020-08-28 주식회사 코피텍 Film-coated tablet having high damp proof property
KR102381836B1 (en) 2019-10-22 2022-04-05 한국유나이티드제약 주식회사 Minimized and Sustained Released Pharmaceutical Dosage Form Comprising Choline Alfoscerate
KR102285886B1 (en) 2019-10-22 2021-08-05 한국유나이티드제약 주식회사 Sustained-Release Minimized Oral Dosage Formulation Comprising Choline Alfoscerate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101172699B1 (en) * 2011-05-16 2012-08-09 한국프라임제약주식회사 Pharmaceutical preparation comprising choline alfoscerate, and a method for manufacturing the same
KR101257919B1 (en) * 2011-07-14 2013-04-30 주식회사 바이오파마티스 Solid preparation for oral administration comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR102008490B1 (en) * 2013-01-14 2019-08-08 주식회사 바이오파마티스 Controlled release pharmaceutical composition comprising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same
KR101533286B1 (en) * 2013-12-09 2015-07-03 주식회사한국파마 Oral pharmaceutical compositions comprising choline alfoscerate and a method for preparing the same
KR101556568B1 (en) * 2013-12-17 2015-10-01 주식회사 대웅제약 Film coated tablet containing choline alfoscerate and process for preparing the same

Also Published As

Publication number Publication date
PH12018502287A1 (en) 2019-07-15
WO2017204548A1 (en) 2017-11-30
KR101796628B1 (en) 2017-11-10

Similar Documents

Publication Publication Date Title
PH12018502287A1 (en) Moisture-proof tablet containing choline alfoscerate and method for producing the same
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
MY190561A (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2015008427A (en) Dry granulation process for producing tablet compositions of metformin and compositions thereof.
GT201600142A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING AZD9291
WO2015195848A8 (en) Ezh2 inhibitors for treating lymphoma
MD20140073A2 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
MX2022015606A (en) Immediate-release tablets containing a drug and processes for forming the tablets.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
PH12018501237A1 (en) Isoindole compounds
EA201992020A1 (en) PHARMACEUTICAL COMBINED COMPOSITION OF CAPSULES CONTAINING TADALAFIL AND TAMSULOSIN
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EA202090913A1 (en) COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2018008153A (en) C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same.
EA033291B1 (en) Dosage unit comprising ramipril and bisoprolol hemifumarate, process for the preparation thereof and method of treating hypertension
MX2016006464A (en) Pharmaceutical composition of a combination of tramadol-etoricoxib hydrochloride for the treatment of pain.
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
WO2015114656A3 (en) Mucoadhesive tablet of pregabalin
RU2013107724A (en) PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST AND LEVOCETIRISINE
EA201400808A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS OF A STRONGLY ACTIVE HEPATITIS VIRUS INHIBITOR
MX2015011854A (en) Pharmaceutical composition based on loratadine-phenylephrine for forming a capsule, for the cold treatment among other allopathies.
MX2021003355A (en) Pharmaceutical composition containing alkyl carbamoyl naphthalenyloxy octenoyl hydroxyamide phosphate, tartrate or combination thereof, and preparation method therefor.
MX2015011152A (en) Omeprazole-sodium bicarbonate pharmaceutical composition to integrate a capsule for the treatment of heartburn related allopathies.
WO2016153222A3 (en) Pharmaceutical composition comprising potassium salt of telmisartan, and preparation method therefor